bioRxiv ScienceSearch

bioRxiv · 10.1101/135517

Systems-Level Analysis Of 32 TCGA Cancers Reveals Disease-Dependent tRNA Fragmentation Patterns And Very Selective Associations With Messenger RNAs And Repeat Elements

Abstract

We mined 10,274 datasets from The Cancer Genome Atlas (TCGA) for tRNA fragments (tRFs) that overlap nuclear and mitochondrial (MT) mature tRNAs. Across 32 cancer types, we identified 20,722 distinct tRFs, a third of which arise from MT tRNAs. Most of the fragments belong to the novel category of i-tRFs, i.e. they are wholly internal to the mature tRNAs. The abundances and cleavage patterns of the identified tRFs depend strongly on cancer type. Of note, in all 32 cancer types, we find that tRNAHisGTG produces multiple and abundant 5{acute}-tRFs with a uracil at the -1 position, instead of the expected post-transcriptionally-added guanosine. Strikingly, these -1U His 5{acute}tRFs are produced in ratios that remain constant across all analyzed normal and cancer samples, a property that makes tRNAHisGTG unique among all tRNAs. We also found numerous tRFs to be negatively correlated with many messenger RNAs (mRNAs) that belong primarily to four universal biological processes: transcription, cell adhesion, chromatin organization and development/morphogenesis. However, the identities of the mRNAs that belong to these processes and are negatively correlated with tRFs differ from cancer to cancer. Notably, the protein products of these mRNAs localize to specific cellular compartments, and do so in a cancer-dependent manner. Moreover, the genomic span of mRNAs that are negatively correlated with tRFs are enriched in multiple categories of repeat elements. Conversely, the genomic span of mRNAs that are positively correlated with tRFs are depleted in repeat elements. These findings suggest novel and far-reaching roles for tRFs and indicate their involvement in system-wide interconnections in the cell. All discovered tRFs from TCGA can be downloaded from https://cm.jefferson.edu/tcga-mintmap-profiles or studied interactively through the newly-designed version 2.0 of MINTbase at https://cm.jefferson.edu/MINTbase.\n\nNOTE: while the manuscript is under review, the content on the page https://cm.jefferson.edu/tcgamintmap-profiles is password protected and available only to Reviewers.\n\nKey PointsO_LIComplexity: tRNAs exhibit a complex fragmentation pattern into a multitude of tRFs that are conserved within the samples of a given cancer but differ across cancers.\nC_LIO_LIVery extensive mitochondrial contributions: the 22 tRNAs of the mitochondrion (MT) contribute 1/3rd of all tRFs found across cancers, a disproportionately high number compared to the tRFs from the 610 nuclear tRNAs.\nC_LIO_LIUridylated (not guanylated) 5{acute}-His tRFs: in all human tissues analyzed, tRNAHisGTG produces many abundant modified 5{acute}-tRFs with a U at their \"-1\" position (-1U 5{acute}-tRFs), instead of a G.\nC_LIO_LILikely central roles for tRNAHisGTG: the relative abundances of the -1U 5{acute}-tRFs from tRNAHisGTG remain strikingly conserved across the 32 cancers, a property that makes tRNAHisGTG unique among all tRNAs and isoacceptors.\nC_LIO_LISelective tRF-mRNA networks: tRFs are negatively correlated with mRNAs that differ characteristically from cancer to cancer.\nC_LIO_LIMitochondrion-encoded tRFs are associated with nuclear proteins: in nearly all cancers, and in a cancer-specific manner, tRFs produced by the 22 mitochondrial tRNAs are negatively correlated with mRNAs whose protein products localize to the nucleus.\nC_LIO_LItRFs are associated with membrane proteins: in all cancers, and in a cancer-specific manner, nucleus-encoded and MT-encoded tRFs are negatively correlated with mRNAs whose protein products localize to the cells membrane.\nC_LIO_LItRFs are associated with secreted proteins: in all cancers, and in a cancer-specific manner, nucleusencoded and MT-encoded tRFs are negatively correlated with mRNAs whose protein products are secreted from the cell.\nC_LIO_LItRFs are associated with numerous mRNAs through repeat elements: in all cancers, and in a cancerspecific manner, the genomic span of mRNAs that are negatively correlated with tRFs are enriched in specific categories of repeat elements.\nC_LIO_LIintra-cancer tRF networks can depend on sex and population origin: within a cancer, positive and negative tRF-tRF correlations can be modulated by patient attributes such as sex and population origin.\nC_LIO_LIweb-enabled exploration of an \"Atlas for tRFs\": we released a new version of MINTbase to provide users with the ability to study 26,531 tRFs compiled by mining 11,719 public datasets (TCGA and other sources).\nC_LI

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Rigoutsos, I., Telonis, A. G., Loher, P., Magee, R., Kirino, Y., Pliatsika, V.. 2017-05-09. Systems-Level Analysis Of 32 TCGA Cancers Reveals Disease-Dependent tRNA Fragmentation Patterns And Very Selective Associations With Messenger RNAs And Repeat Elements. https://doi.org/10.1101/135517

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology